|Other Names||Putative E3 ubiquitin-protein ligase SH3RF2, 632-, Heart protein phosphatase 1-binding protein, HEPP1, Protein phosphatase 1 regulatory subunit 39, RING finger protein 158, SH3 domain-containing RING finger protein 2, SH3RF2, PPP1R39, RNF158|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Inhibits PPP1CA phosphatase activity. May be a E3 ubiquitin-protein ligase (Potential). May play a role in cardiac function.|
|Tissue Location||Heart (at protein level). Heart and testis. In the heart, present in the apex, left atrium, right atrium, left ventricle and right ventricle, but not in the aorta|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
SH3RF2 may be a E3 ubiquitin-protein ligase (Potential).
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Chen, C.Y., et al. Biochem. Biophys. Res. Commun. 391(1):698-702(2010)Voss, M., et al. BMC Immunol. 10, 53 (2009) :
If you have any additional inquiries please email technical services at email@example.com.